*Aurinia Pharmaceuticals Inc.

Changing the course of autoimmune disease

Inspired by patients. Driven to make an impact.

Latest News

May 20, 2022 • 12:07pm EDT

Aurinia Presents Results from the Two-Year AURORA 2 Continuation Study at the 2022 European Renal Association (ERA) Congress

Read Press Release View All News

May 16, 2022 • 7:17am EDT

Aurinia Pharmaceuticals Announces Presentations at the 2022 ERA Congress and the 2022 EULAR Congress

Read Press Release View All News

May 10, 2022 • 6:00am EDT

Aurinia Reports First Quarter 2022 Financial and Operational Results

Read Press Release View All News